Developing Protein-Based Vaccines for SARS-CoV-2
In 2018, SK bioscience spun off from SK chemicals, thus establishing a fully integrated vaccine company based in Seongnam, South Korea. The company signed a contract manufacturing organization (CMO) agreement with AstraZeneca in 2020 to manufacture and …